CRISPR Therapeutics vs Precision BioSciences

CRISPR Therapeutics vs Precision BioSciences, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and Precision BioSciences on 57/100.

CRISPR Therapeutics logo
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Try CRISPR Therapeutics
Precision BioSciences logo
Precision BioSciencesA clinical-stage biotechnology company developing in vivo gene editing therapies.
Try Precision BioSciences

Where each one leads

CRISPR Therapeutics

  • our overall score: 64/100 against 57/100
  • agent readiness: 44/100 against 37/100
  • domain rating: 67/100 against 54/100
  • funding raised: $547M against $358M

Precision BioSciences

Leads on none of the measures we hold for both companies.

At a glance

MeasureCRISPR TherapeuticsPrecision BioSciences
What it isBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.A clinical-stage biotechnology company developing in vivo gene editing therapies.
CategoryBiotechnology, Gene Editing, Therapeutics, PharmaceuticalsBiotechnology, Genetics, Pharmaceuticals, HealthTech
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20132006
HeadquartersZug, SwitzerlandDurham, USA
StatusActiveActive

Size, funding and growth

MeasureCRISPR TherapeuticsPrecision BioSciences
EmployeesNot published97
Total funding$547M$358M
Latest roundSeries BMilestone Payment
ValuationNot published$1.1B

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCRISPR TherapeuticsPrecision BioSciences
StartupHub scoreOur 0-100 rating64/10057/100
Traction40/10060/100
Team70/10090/100
Search visibility13/10014/100
Quality88/10065/100
Agent readinessHow well an AI agent can read and act on the siteD (44/100)F (37/100)
Domain ratingLink authority, 0-10067/10054/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCRISPR TherapeuticsPrecision BioSciences
HostingSelf ManagedGoogle Cloud
CMSNot detectedWordPress
FrameworksJqueryJquery, Bootstrap
AnalyticsGoogle Analytics 4Not detected

CRISPR Therapeutics vs Precision BioSciences: common questions

Which is better, CRISPR Therapeutics or Precision BioSciences?

On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do CRISPR Therapeutics and Precision BioSciences compare on the numbers?

CRISPR Therapeutics leads on our overall score (64/100 against 57/100), agent readiness (44/100 against 37/100), domain rating (67/100 against 54/100), funding raised ($547M against $358M).

Read the full CRISPR Therapeutics review and pricing or the Precision BioSciences review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.